Preussmann R, Habs M, Pool B L
J Natl Cancer Inst. 1979 Jan;62(1):153-6.
Three isomeric N-nitroso-N-methylaminopyridines (NMPY's) were investigated for their carcinogenic activity in BD VI rats following chronic oral administration and for their mutagenic properties in the Ames assay. On the basis of postulated reaction mechanisms, it was expected that 3-NMPY would react differently than 2- and 4-NMPY, but the outcome of both carcinogenicity and mutagenicity assays did not show this. 2-NMPY induced tumors of the esophagus and possibly also of the liver; 3- and 4-NMPY had no activity as carcinogens under the experimental conditions used. Similarly, high concentrations of 2-NMPY showed mutagenic activity toward Salmonella typhimurium TA100, whereas 3- and 4-NMPY did not have such an effect.
研究了三种异构的N-亚硝基-N-甲基氨基吡啶(NMPY's)在长期口服给药后对BD VI大鼠的致癌活性以及它们在艾姆斯试验中的致突变特性。根据假定的反应机制,预计3-NMPY的反应与2-和4-NMPY不同,但致癌性和致突变性试验的结果均未显示出这种差异。2-NMPY诱发了食管肿瘤,可能还诱发了肝脏肿瘤;在所用的实验条件下,3-和4-NMPY没有致癌活性。同样,高浓度的2-NMPY对鼠伤寒沙门氏菌TA100显示出致突变活性,但3-和4-NMPY没有这种作用。